Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Shanghai Jiao Tong University School of Medicine: Clinical Trials & FDA Approval Profile

Shanghai Jiao Tong University School of Medicine (Global / Institutional) sponsors 50 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 26 active protocols (17 recruiting now), 7 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)2.0%
Median Closed Enrollment vs National (145 pts)36 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Shanghai Jiao Tong University School of Medicine
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)50
Active Pipeline (Recruiting Now)26 (17)
Completed vs Stopped Early7 / 1 (2.0%)
Median Closed Actual Enrollment36 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Shanghai Jiao Tong University School of Medicine
Hospital Research SiteLocationShared Protocols
Ruijin HospitalShanghai4
Ruijin Hospital, Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Shanghai Jiao Tong University School of Medicine
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07303803A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes MellitusPhase IIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Shanghai Jiao Tong University School of Medicine Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI